| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| SNY | Sanofi | $43.75 | $109.14B | Sell |
Why Sanofi Won't Try To Buy Bristol-Myers
https://seekingalpha.com/article/4243375-sanofi-try-buy-bristol-myers?source=feed_sector_healthcare
Feb 22, 2019 - There are twitter rumors that Sanofi wants to buy Bristol-Myers.Strategically, it fits the profile of an acquisition Sanofi would want.However, there are a number of important reasons why it is unlike
0
Regeneron and Sanofi prevail in review of Amgen's IL-4 receptor patent
https://seekingalpha.com/news/3434167-regeneron-sanofi-prevail-review-amgens-ilminus-4-receptor-patent?source=feed_news_all
Feb 16, 2019 - Regeneron Pharmaceuticals (NASDAQ:REGN) and development partner Sanofi (NASDAQ:SNY) announce that the USPTO has invalidated 17 claims as obvious of U.S. Patent No. 8,679,487 owned by Amgen's (NASDAQ:A
0
Ascendis Pharma Files IND for Hypoparathyroidism Candidate
http://www.zacks.com/stock/news/354249/ascendis-pharma-files-ind-for-hypoparathyroidism-candidate?cid=CS-ZC-FT-354249
Feb 13, 2019 - Ascendis Pharma (ASND) submits regulatory application to initiate a phase II study in the United States on its hypoparathyroidism therapy candidate, TransCon PTH.
0
Sanofi and Regeneron to cut price of Praluent
https://seekingalpha.com/news/3431580-sanofi-regeneron-cut-price-praluent?source=feed_news_all
Feb 11, 2019 - Regeneron Pharmaceuticals (NASDAQ:REGN) and development partner Sanofi (NASDAQ:SNY) will adjust the U.S. list price of cholesterol med Praluent (alirocumab) to $5,850 effective next month. Out-of-pock
0
Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs
http://www.zacks.com/stock/news/353203/pharma-stock-roundup-q4-earnings-at-mrk-lly-chmp-nod-for-several-drugs?cid=CS-ZC-FT-353203
Feb 08, 2019 - Merck (MRK) and Lilly (LLY) report Q4 results. CHMP gives nod to several drugs.
0
Alnylam's (ALNY) Q4 Earnings and Revenues Beat Estimates
http://www.zacks.com/stock/news/353200/alnylams-alny-q4-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-353200
Feb 08, 2019 - Alnylam (ALNY) incurs wider year-over-year loss in the fourth quarter of 2018.
0
Sanofi (SNY) CEO Olivier Brandicourt on Q4 2018 Results - Earnings Call Transcript
https://seekingalpha.com/article/4239163-sanofi-sny-ceo-olivier-brandicourt-q4-2018-results-earnings-call-transcript?source=feed_sector_healthcare
Feb 07, 2019 -
0
Sanofi 2018 Q4 - Results - Earnings Call Slides
https://seekingalpha.com/article/4238983-sanofi-2018-q4-results-earnings-call-slides?source=feed_sector_healthcare
Feb 07, 2019 -
0
Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth
http://www.zacks.com/stock/news/352788/sanofi-sny-q4-earnings-top-genzyme-unit-drives-sales-growth?cid=CS-ZC-FT-352788
Feb 07, 2019 - Sanofi (SNY) beat estimates for earnings and missed the same for sales in the fourth quarter. The Specialty Care unit drove top-line growth.
0
Sanofi guides +5% net income for 2019
https://seekingalpha.com/news/3430599-sanofi-guides-plus-5-percent-net-income-2019?source=feed_news_all
Feb 07, 2019 - Sanofi (NASDAQ:SNY) expects net income to increase by 3% to 5% in 2019 through a combination of new drug launches and reorganization.Sanofi's Q4 net income was up 4.3% in constant currency to 1.36B eu
0
Page 1>
Related Companies
| Name | Exchange | Price | Mkt Cap | |
| LLY | Eli Lilly and Company | NYSE | $105.71 | $113.53B |
| NVO | Novo Nordisk A/S | NYSE | $47.64 | $114.84B |
| BMY | Bristol-Myers Squibb Company | NYSE | $61.3 | $100.03B |
| ABT | Abbott Laboratories | NYSE | $67.67 | $118.71B |
| GSK | GlaxoSmithKline PLC | NYSE | $39.21 | $97.25B |
SNY - Nasdaq
http://www.nasdaq.com/symbol/sny
Quote information directly from the exchange
SEC filings
Comparison
Ownership
Insiders
Institutions
Revenue/EPS
Competitors
Guru
Report
Analysts
Pre-market
Quote
Consultant
After hours
Transcripts
SNY - Google Finance
https://www.google.com/finance?q=SNY
Industry related info and international coverage
Summary
News
SNY - Bloomberg
http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=SNY
Original news and commentary from Bloomberg
Charts
Financials with pensions
Snapshot
Earnings
Transactions
People
Options